This podcast episode covers the highlights from this year’s American Society of Hematology Annual Meeting that took place in New Orleans in early December. There was enormous excitement for novel therapies for blood cancers and for diseases that previously had very high morbidity and mortality and now, because of novel treatment modalities in the field of hematology, like T cell engagers and CAR-T cell therapies, patients outcomes are being improved.